Interaction between bFGF and anti-angiogenic drug suradista: A possible induced-fit mechanism.

被引：0
|
作者：
Parola, AH
Hariharan, C
Cohen-Luria, R
Moreno, Z
Pines, E
Yayon, A
机构：
[1] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel
[2] Pharmacia & Upjohn Inc, Milan, Italy
[3] Weizmann Inst Sci, Dept Mol & Cellular Biol, IL-76100 Rehovot, Israel
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2000年 / 220卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
470-PHYS
引用
收藏
页码：U225 / U225
页数：1
相关论文
共 47 条
  • [31] Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model
    Kim, Jinil
    Choi, Sang Hyun
    Ham, Su Jung
    Cho, Young Chul
    Lee, Seul-I
    Kang, Jeeheon
    Woo, Dong-Cheol
    Lee, Weon Sub
    Yoo, Jin-San
    Kim, Kyung Won
    Choi, Yoonseok
    PLOS ONE, 2018, 13 (01):
  • [32] Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor - A possible mechanism for the anti-angiogenic activity of plasminogen kringle 5
    Gao, GQ
    Li, Y
    Gee, S
    Dudley, A
    Fant, J
    Crosson, C
    Ma, JX
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) : 9492 - 9497
  • [33] Suppression of anti-microtubule agent-induced apoptosis by nitric oxide: Possible mechanism of a new drug resistance
    Ogura, T
    DeGeorge, G
    Tatemichi, M
    Esumi, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (02): : 199 - 205
  • [34] Picosecond time-resolved fluorescence studies characterize the binding between the novel fluorescent anti-angiogenic drug PNU151484 and human basic fibroblast growth factor
    Parola, AH
    Zamai, M
    Caiolfa, VR
    Pines, D
    Pines, E
    FASEB JOURNAL, 1997, 11 (09): : A1426 - A1426
  • [35] Picosecond time-resolved fluorescence studies characterize the binding between the novel fluorescent anti-angiogenic drug PNU151484 and human basic fibroblast growth factor
    Zamai, M
    Caiolfa, VR
    Pines, D
    Pines, E
    Parola, AH
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : MP364 - MP364
  • [36] Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody
    Wang, Weirong
    Leu, Jocelyn
    Watson, Rebecca
    Xu, Zhenhua
    Zhou, Honghui
    AAPS JOURNAL, 2018, 20 (03):
  • [37] Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody
    Weirong Wang
    Jocelyn Leu
    Rebecca Watson
    Zhenhua Xu
    Honghui Zhou
    The AAPS Journal, 20
  • [38] INTERACTION BETWEEN QUERCETIN AND CA-2+-CALMODULIN COMPLEX - POSSIBLE MECHANISM FOR ANTI-TUMOR-PROMOTING ACTION OF THE FLAVONOID
    NISHINO, H
    NAITO, E
    IWASHIMA, A
    TANAKA, K
    MATSUURA, T
    FUJIKI, H
    SUGIMURA, T
    GANN, 1984, 75 (04): : 311 - 316
  • [39] The interaction between IL-1β and morphine:: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice
    Gul, H
    Yildiz, O
    Dogrul, A
    Yesilyurt, O
    Isimer, A
    PAIN, 2000, 89 (01) : 39 - 45
  • [40] Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin
    Sauzay, C.
    White-Koning, M.
    Hennebelle, I.
    Deluche, T.
    Delmas, C.
    Imbs, D. C.
    Chatelut, E.
    Thomas, F.
    PHARMACOLOGICAL RESEARCH, 2016, 110 : 89 - 95
12345